For the time being, a GnRHa trigger followed by iLPS can be recommended for patients with PCOS, given the high endogenous LH levels and risk of OHSS in these patients, even with low-dose hCG administration. The gene discussed is PLOD1; the disease is polycystic ovary syndrome.